NewNow you can hear Fox News article!
Food and Drug Administration Commissioner Marthi Makeri said in an interview recently that he has a “no predetermined plan” to revise the policies around the abortion tablet Mifiprystone, designed to end pregnancy in the first 10 weeks.
Mary said in an interview, “We have a continuous review of security data on Mifepristone, which is a requirement from the former administration.” Political“You will always have to be open-minded. You have to listen to different opinions and which you think will have to decide on the basis of doing the right thing.”
His comments gave mirrors to those whom he made Semaphor World Economy Summit In April.
During the summit, Makari said that he had “no plans to take action” which would ban the availability of abortion drugs, but would not hesitate to take action to the warning agency if the data was suggested that the security issue was suggested.
Abortion pill Mifepristone provoked new life debate as some doctors
Drug mifiprystone boxes sit on a shelf at West Alabama Women’s Center on March 16, 2022, Tuskalosa, Ala. On Tuesday, March 26, 2024, the US Supreme Court will raise a case that can reach women mifiprystone, one of the two bullets, used in the most common types of abortion in the country.
“There is a set of data that is coming in FDA on MIFEPRISTONE,” he said. “So if the data gives some suggestions or tells us that there is a real signal, we cannot promise that we are not going to work on that data.”
Sen Josh Hale, R-Mo., wrote a letter to Maki on 28 April about safety concerns about Mifepristone.
The Senator introduces the law to curb the dispute, controversial abortion pill
Dr. Makeri is a cancer surgeon, a researcher at the University of Johns Hopkins, and has also been a Fox News commentator. (Getty image)
Hale wrote, “I urge you to take all appropriate action to follow this new data and restore significant safety measures on the use of mifaprystone. The health and safety of American women depends on it.”
Click here to get Fox News app
Mifepristone (MIFEPREX) and Misoprostol, two drugs used in a drug abortion, are seen in women’s breeding clinics, which offers legal medicine abortion services in Santa Teresa, New Mexico on 17 June 2022. (Through Robin Bake/AFP Getty Image)
Makeri said during an interview with Politico that he had no plans to “make any changes” with the policy about mifepistone, saying that he would “listen to those who say that they are worried.”
Fox News reached FDA and Sen Hale for digital comments.
